Study Links Modifiable Risk Factors to High-Risk Plaques in Heart Disease
A new study has provided insights into how certain cardiovascular risk factors can influence the likelihood of adverse cardiac events, such as heart attacks. Conducted by researchers at Mass General Brigham Heart and Vascular Institute, the study examined the relationship between both modifiable and non-modifiable risk factors and the types of plaques found in the coronary arteries. Modifiable risk factors include those that individuals can change, such as high blood pressure, obesity, and smoking, while non-modifiable factors include age, sex, and family history of coronary artery disease. Previous research has typically focused on these factors in isolation or within specific patient groups. This study, published in JACC: Advances, took a comprehensive approach by analyzing the cumulative impact of these risk factors on plaque formation. The researchers utilized optical coherence tomography (OCT) imaging to assess 131 patients from the Massachusetts General Hospital registry who had not received prior treatment for blocked or narrowed coronary arteries. This advanced imaging technique allowed for detailed cross-sectional images of the blood vessels, revealing a total of 534 plaques across all participants. The analysis indicated that an increase in the number of risk factors was associated with a higher number of plaques visible in the OCT imaging. Notably, the study identified a greater prevalence of high-risk plaque types, including thin-cap fibroatheromas, which are more likely to lead to adverse cardiac events. Among participants with at least four modifiable risk factors, half of the plaques were identified as thin-cap fibroatheromas, while four out of five were lipid-rich plaques. Senior author Dr. Ik-Kyung Jang noted that the presence of more vulnerable plaques increases the likelihood of triggering adverse events. The study found that only the increase in modifiable risk factors was linked to a greater distribution of these high-risk plaques, while non-modifiable factors were associated with more stable plaque types. Dr. Jang explained that the correlation between modifiable risk factors and plaque vulnerability is likely mediated by inflammation, as all five identified modifiable factors—dyslipidemia, hypertension, diabetes, obesity, and smoking—are known to promote vascular inflammation. In contrast, non-modifiable factors may contribute to atherosclerosis progression through less direct pathways. The researchers suggest that future studies should investigate whether aggressive management of modifiable risk factors can effectively reduce plaque vulnerability. They acknowledge limitations in their study, noting that the findings may not be generalizable to a broader population due to the specific patient pool analyzed. To validate their results, further research involving larger and more diverse groups, including those who have received treatment for blocked arteries, is necessary. Until then, the study underscores the critical need to address modifiable risk factors to help prevent heart attacks. Dr. Jang emphasized the importance of early and sustained interventions to manage these risk factors and mitigate future cardiac events.




